Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. (Q53664103)

17 May 2018

title

Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. (English)

1 reference

17 May 2018

author name string

Ik-Jae Lee

1

1 reference

17 May 2018

Kyung-Ran Park

2

1 reference

17 May 2018

Kang-Kyoo Lee

3

1 reference

17 May 2018

Ji-Sun Song

4

1 reference

17 May 2018

Kwang-Gil Lee

5

1 reference

17 May 2018

Jong-Young Lee

6

1 reference

17 May 2018

Dong-Soo Cha

7

1 reference

17 May 2018

Hyun-Il Choi

8

1 reference

17 May 2018

Dong-Hee Kim

9

1 reference

17 May 2018

Young-Kun Deung

10

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 November 2002

1 reference

17 May 2018

number of pages

12

1 reference

International Journal of Radiation Oncology Biology Physics

inferred from page(s)

published in

1 reference

17 May 2018

volume

54

1 reference

17 May 2018

issue

3

1 reference

17 May 2018

page(s)

768-779

1 reference

17 May 2018

Cervical and vulva cancer: changes in FIGO definitions of staging

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

The role of vascular endothelial growth factor in pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Oxygenation predicts radiation response and survival in patients with cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Vascular endothelial growth factor in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Vascular endothelial growth factor and prognosis of cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Molecular mechanisms of tumor angiogenesis and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

1 reference

7 January 2021

Angiogenesis: new targets for the development of anticancer chemotherapies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Angiogenesis: regulators and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Genes that regulate metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Tumor angiogenesis: an independent prognostic parameter in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Angiogenesis in uterine cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Tumor angiogenesis as a prognostic factor in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Different angiogenic pathways in human cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

Vascular endothelial growth factor is implicated in early invasion in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902970-X

7 January 2021

10.1016/S0360-3016(02)02970-X

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018